脑部放疗，上午比下午敏感许多！, z9 M% `3 }4 D5 s6 l7 U
7 g8 l k6 W" M
& P' \1 `; o% Q+ fCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.8 q/ ?* X5 d. p3 R* C, q
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
! R* V: q2 J: |/ pRahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.% H/ w0 C, O( c2 q) r" B
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.. V! u; A+ q7 e+ c: K6 f0 E
. M4 Y0 F. Q$ W) B3 _
Abstract
* l$ a' w3 j' ~" D- U. UBACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.& g7 _) a9 N6 \. i+ ` v9 c/ c
/ n( x% n2 H6 R! \! ]7 cMETHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.! S, ?) v$ j2 g
3 A; R7 h' ^* b7 A/ m# s5 qRESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
5 G4 b4 D4 P3 g& N
1 {5 T5 O- s% i$ a/ B/ v! @* tCONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.) X" r3 @ M' J. X* m$ F! p, ~1 L' }
+ H' d2 _; @+ h) R8 N |
8 K2 ]$ z& `5 g1 b
显身卡
